PUBLISHER: KBV Research | PRODUCT CODE: 1335993
PUBLISHER: KBV Research | PRODUCT CODE: 1335993
LAMEA API Intermediate Market Size, Share & Industry Trends Analysis Report By Type, By End User, By Application, By Country and Growth Forecast, 2023 - 2030
The Latin America, Middle East and Africa API Intermediate Market would witness market growth of 10.7% CAGR during the forecast period (2023-2030).
The production of APIs requires a large amount of capital due to the process' need for highly systematic protocols, which results in the outsourcing of various APIs. Outsourcing API production offers pharmaceutical companies' additional advantages because it eliminates the need for costly manufacturing unit installation and labor costs. Thus, outsourcing is encouraged by the need for cost savings. Strategic outsourcing enables companies to concentrate on their core competencies, resulting in increased productivity.
A drug's intended effects are achieved through an active pharmaceutical ingredient. They are also referred to as bulk medications. A chemical or biological process produces these. The expanding tendency toward improvements and developments in therapeutic medications by various pharmaceutical and biotechnology companies is projected to benefit the market. The rise of innovative drug delivery systems, and the increasing demand for personalized medication are a few of the factors anticipated to significantly contribute to the growth of the market during the projected year.
According to statistics provided by the UAE's government under Chronic Illness & Natural Disorders in March 2023, the UAE reports 4,500 new cancer cases yearly. The primary performance metric of the pillar of top-notch healthcare in the UAE National Agenda 2021 is lowering the prevalence of diabetes and cancer-related mortality. Furthermore, creating a top-notch healthcare sector is the aim of the UAE's government. Also, they wish to build their healthcare sector as a hub for medical tourism. This high number of patients with health issues such as diabetes mainly need products such as API intermediate. Also, other regional nations such as Brazil, and Saudi Arabia have robust healthcare sector. All these aspects are predicted to support the growth of regional market.
The Brazil market dominated the LAMEA API Intermediate Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $3.8 billion by 2030. The Argentina market is estimated to grow at a CAGR of 11.3% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 10.4% during (2023 - 2030).
Based on Type, the market is segmented into Bulk Drug Intermediates, and Chemical Intermediates. Based on End User, the market is segmented into Biotech & Pharmaceutical Companies, CMO, and Others. Based on Application, the market is segmented into Analgesics, Antidiabetic Drugs, Anti-Infective Drugs, Cardiovascular Drugs, Anticancer Drugs, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cation Pharma, Espee Group, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Cipla Limited, Cambrex Corporation, Vertellus, Dr. Reddy's Laboratories Ltd., Evonik Industries AG (RAG-Stiftung), Pfizer, Inc., Shree Ganesh Remedies Limited
Scope of the Study
Market Segments covered in the Report:
By Type
- Bulk Drug Intermediates
- Chemical Intermediates
By End User
- Biotech & Pharmaceutical Companies
- CMO
- Others
By Application
- Analgesics
- Antidiabetic Drugs
- Anti-Infective Drugs
- Cardiovascular Drugs
- Anticancer Drugs
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Cation Pharma
- Espee Group
- Sandoo Pharmaceuticals and Chemicals Co., Ltd.
- Cipla Limited
- Cambrex Corporation
- Vertellus
- Dr. Reddy's Laboratories Ltd.
- Evonik Industries AG (RAG-Stiftung)
- Pfizer, Inc.
- Shree Ganesh Remedies Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA API Intermediate Market, by Type
- 1.4.2 LAMEA API Intermediate Market, by End User
- 1.4.3 LAMEA API Intermediate Market, by Application
- 1.4.4 LAMEA API Intermediate Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Forces Analysis
Chapter 4. Strategies Deployed in API Intermediate Market
Chapter 5. LAMEA API Intermediate Market by Type
- 5.1 LAMEA Bulk Drug Intermediates Market by Country
- 5.2 LAMEA Chemical Intermediates Market by Country
Chapter 6. LAMEA API Intermediate Market by End User
- 6.1 LAMEA Biotech & Pharmaceutical Companies Market by Country
- 6.2 LAMEA CMO Market by Country
- 6.3 LAMEA Others Market by Country
Chapter 7. LAMEA API Intermediate Market by Application
- 7.1 LAMEA Analgesics Market by Country
- 7.2 LAMEA Antidiabetic Drugs Market by Country
- 7.3 LAMEA Anti-Infective Drugs Market by Country
- 7.4 LAMEA Cardiovascular Drugs Market by Country
- 7.5 LAMEA Anticancer Drugs Market by Country
- 7.6 LAMEA Others Market by Country
Chapter 8. LAMEA API Intermediate Market by Country
- 8.1 Brazil API Intermediate Market
- 8.1.1 Brazil API Intermediate Market by Type
- 8.1.2 Brazil API Intermediate Market by End User
- 8.1.3 Brazil API Intermediate Market by Application
- 8.2 Argentina API Intermediate Market
- 8.2.1 Argentina API Intermediate Market by Type
- 8.2.2 Argentina API Intermediate Market by End User
- 8.2.3 Argentina API Intermediate Market by Application
- 8.3 UAE API Intermediate Market
- 8.3.1 UAE API Intermediate Market by Type
- 8.3.2 UAE API Intermediate Market by End User
- 8.3.3 UAE API Intermediate Market by Application
- 8.4 Saudi Arabia API Intermediate Market
- 8.4.1 Saudi Arabia API Intermediate Market by Type
- 8.4.2 Saudi Arabia API Intermediate Market by End User
- 8.4.3 Saudi Arabia API Intermediate Market by Application
- 8.5 South Africa API Intermediate Market
- 8.5.1 South Africa API Intermediate Market by Type
- 8.5.2 South Africa API Intermediate Market by End User
- 8.5.3 South Africa API Intermediate Market by Application
- 8.6 Nigeria API Intermediate Market
- 8.6.1 Nigeria API Intermediate Market by Type
- 8.6.2 Nigeria API Intermediate Market by End User
- 8.6.3 Nigeria API Intermediate Market by Application
- 8.7 Rest of LAMEA API Intermediate Market
- 8.7.1 Rest of LAMEA API Intermediate Market by Type
- 8.7.2 Rest of LAMEA API Intermediate Market by End User
- 8.7.3 Rest of LAMEA API Intermediate Market by Application
Chapter 9. Company Profiles
- 9.1 Cation Pharma
- 9.1.1 Company Overview
- 9.1.2 SWOT Analysis
- 9.2 Espee Group
- 9.2.1 Company Overview
- 9.2.2 Recent strategies and developments:
- 9.2.2.1 Trials and Approvals:
- 9.3 Sandoo Pharmaceuticals and Chemicals Co., Ltd.
- 9.3.1 Company Overview
- 9.3.2 SWOT Analysis
- 9.4 Cipla Limited
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
- 9.5 Cambrex Corporation
- 9.5.1 Company Overview
- 9.5.2 Recent strategies and developments:
- 9.5.2.1 Acquisition and Mergers:
- 9.5.3 SWOT Analysis
- 9.6 Vertellus
- 9.6.1 Company Overview
- 9.6.2 SWOT Analysis
- 9.7 Dr. Reddy's Laboratories Ltd.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expense
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Partnerships, Collaborations, and Agreements:
- 9.7.6 SWOT Analysis
- 9.8 Evonik Industries AG (RAG-Stiftung)
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
- 9.8.5.1 Partnerships, Collaborations, and Agreements:
- 9.8.5.2 Geographical Expansions:
- 9.8.6 SWOT Analysis
- 9.9 Pfizer, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional & Segmental Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Geographical Expansions:
- 9.9.6 SWOT Analysis
- 9.10. SHREE GANESH REMEDIES LIMITED
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 SWOT Analysis
LIST OF TABLES
- TABLE 1 LAMEA API Intermediate Market, 2019 - 2022, USD Million
- TABLE 2 LAMEA API Intermediate Market, 2023 - 2030, USD Million
- TABLE 3 LAMEA API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 4 LAMEA API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 5 LAMEA Bulk Drug Intermediates Market by Country, 2019 - 2022, USD Million
- TABLE 6 LAMEA Bulk Drug Intermediates Market by Country, 2023 - 2030, USD Million
- TABLE 7 LAMEA Chemical Intermediates Market by Country, 2019 - 2022, USD Million
- TABLE 8 LAMEA Chemical Intermediates Market by Country, 2023 - 2030, USD Million
- TABLE 9 LAMEA API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 10 LAMEA API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 11 LAMEA Biotech & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Million
- TABLE 12 LAMEA Biotech & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Million
- TABLE 13 LAMEA CMO Market by Country, 2019 - 2022, USD Million
- TABLE 14 LAMEA CMO Market by Country, 2023 - 2030, USD Million
- TABLE 15 LAMEA Others Market by Country, 2019 - 2022, USD Million
- TABLE 16 LAMEA Others Market by Country, 2023 - 2030, USD Million
- TABLE 17 LAMEA API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 18 LAMEA API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 19 LAMEA Analgesics Market by Country, 2019 - 2022, USD Million
- TABLE 20 LAMEA Analgesics Market by Country, 2023 - 2030, USD Million
- TABLE 21 LAMEA Antidiabetic Drugs Market by Country, 2019 - 2022, USD Million
- TABLE 22 LAMEA Antidiabetic Drugs Market by Country, 2023 - 2030, USD Million
- TABLE 23 LAMEA Anti-Infective Drugs Market by Country, 2019 - 2022, USD Million
- TABLE 24 LAMEA Anti-Infective Drugs Market by Country, 2023 - 2030, USD Million
- TABLE 25 LAMEA Cardiovascular Drugs Market by Country, 2019 - 2022, USD Million
- TABLE 26 LAMEA Cardiovascular Drugs Market by Country, 2023 - 2030, USD Million
- TABLE 27 LAMEA Anticancer Drugs Market by Country, 2019 - 2022, USD Million
- TABLE 28 LAMEA Anticancer Drugs Market by Country, 2023 - 2030, USD Million
- TABLE 29 LAMEA Others Market by Country, 2019 - 2022, USD Million
- TABLE 30 LAMEA Others Market by Country, 2023 - 2030, USD Million
- TABLE 31 LAMEA API Intermediate Market by Country, 2019 - 2022, USD Million
- TABLE 32 LAMEA API Intermediate Market by Country, 2023 - 2030, USD Million
- TABLE 33 Brazil API Intermediate Market, 2019 - 2022, USD Million
- TABLE 34 Brazil API Intermediate Market, 2023 - 2030, USD Million
- TABLE 35 Brazil API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 36 Brazil API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 37 Brazil API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 38 Brazil API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 39 Brazil API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 40 Brazil API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 41 Argentina API Intermediate Market, 2019 - 2022, USD Million
- TABLE 42 Argentina API Intermediate Market, 2023 - 2030, USD Million
- TABLE 43 Argentina API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 44 Argentina API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 45 Argentina API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 46 Argentina API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 47 Argentina API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 48 Argentina API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 49 UAE API Intermediate Market, 2019 - 2022, USD Million
- TABLE 50 UAE API Intermediate Market, 2023 - 2030, USD Million
- TABLE 51 UAE API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 52 UAE API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 53 UAE API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 54 UAE API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 55 UAE API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 56 UAE API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 57 Saudi Arabia API Intermediate Market, 2019 - 2022, USD Million
- TABLE 58 Saudi Arabia API Intermediate Market, 2023 - 2030, USD Million
- TABLE 59 Saudi Arabia API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 60 Saudi Arabia API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 61 Saudi Arabia API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 62 Saudi Arabia API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 63 Saudi Arabia API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 64 Saudi Arabia API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 65 South Africa API Intermediate Market, 2019 - 2022, USD Million
- TABLE 66 South Africa API Intermediate Market, 2023 - 2030, USD Million
- TABLE 67 South Africa API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 68 South Africa API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 69 South Africa API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 70 South Africa API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 71 South Africa API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 72 South Africa API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 73 Nigeria API Intermediate Market, 2019 - 2022, USD Million
- TABLE 74 Nigeria API Intermediate Market, 2023 - 2030, USD Million
- TABLE 75 Nigeria API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 76 Nigeria API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 77 Nigeria API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 78 Nigeria API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 79 Nigeria API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 80 Nigeria API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 81 Rest of LAMEA API Intermediate Market, 2019 - 2022, USD Million
- TABLE 82 Rest of LAMEA API Intermediate Market, 2023 - 2030, USD Million
- TABLE 83 Rest of LAMEA API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 84 Rest of LAMEA API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 85 Rest of LAMEA API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 86 Rest of LAMEA API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 87 Rest of LAMEA API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 88 Rest of LAMEA API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 89 Key Information - Cation Pharma
- TABLE 90 Key Information - Espee Group
- TABLE 91 Key Information - Sandoo Pharmaceuticals and Chemicals Co., Ltd.
- TABLE 92 Key Information - Cipla Limited
- TABLE 93 Key Information - Cambrex Corporation
- TABLE 94 Key Information - Vertellus
- TABLE 95 key information - Dr. Reddy's Laboratories Ltd.
- TABLE 96 Key Information - Evonik Industries AG
- TABLE 97 Key Information - Pfizer, Inc.
- TABLE 98 Key Information - SHREE GANESH REMEDIES LIMITED
List of Figures
- FIG 1 Methodology for the research
- FIG 2 LAMEA API Intermediate Market, 2019 - 2030, USD Million
- FIG 3 Key Impacting Factors API intermediate market
- FIG 4 Porter's Five Forces Analysis - API Intermediate Market
- FIG 5 LAMEA API Intermediate Market share by Type, 2022
- FIG 6 LAMEA API Intermediate Market share by Type, 2030
- FIG 7 LAMEA API Intermediate Market by Type, 2019 - 2030, USD Million
- FIG 8 LAMEA API Intermediate Market share by End User, 2022
- FIG 9 LAMEA API Intermediate Market share by End User, 2030
- FIG 10 LAMEA API Intermediate Market by End User, 2019 - 2030, USD Million
- FIG 11 LAMEA API Intermediate Market share by Application, 2022
- FIG 12 LAMEA API Intermediate Market share by Application, 2030
- FIG 13 LAMEA API Intermediate Market by Application, 2019 - 2030, USD Million
- FIG 14 LAMEA API Intermediate Market share by Country, 2022
- FIG 15 LAMEA API Intermediate Market share by Country, 2030
- FIG 16 LAMEA API Intermediate Market by Country, 2019 - 2030, USD Million
- FIG 17 Swot Analysis: Cation Pharma
- FIG 18 Swot Analysis: Sandoo Pharmaceuticals and Chemicals Co., Ltd.
- FIG 19 SWOT Analysis: Cipla Limited
- FIG 20 Swot Analysis: Cambrex Corporation
- FIG 21 Swot Analysis: Vertellus
- FIG 22 Swot Analysis: Dr. Reddy's Laboratories Ltd.
- FIG 23 Recent strategies and developments: Evonik Industries AG
- FIG 24 Swot Analysis: Evonik Industries AG
- FIG 25 Swot Analysis: Pfizer, Inc.
- FIG 26 Swot Analysis: SHREE GANESH REMEDIES LIMITED
